A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (10) , 1211-1218
- https://doi.org/10.1023/a:1008361612767
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.Journal of Clinical Oncology, 1998
- Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma IntergroupThe Lancet, 1997
- High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.Journal of Clinical Oncology, 1995
- Osteosarcoma of the trunk treated by multimodal therapy: Experience of the cooperative osteosarcoma study group (COSS)Medical and Pediatric Oncology, 1995
- The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary reportMedical and Pediatric Oncology, 1994
- Osteogenic sarcoma with clinically detectable metastasis at initial presentation.Journal of Clinical Oncology, 1993
- A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.Journal of Clinical Oncology, 1992
- Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.Journal of Clinical Oncology, 1988
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984